Hap Trading, LLC Humanigen, Inc Put Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$3.66 - $8.22 $61,122 - $137,274	-16,700 Reduced 61.85%	10,300 $56,000
Q3 2021 Nov 10, 2021	BUY	$5.93 - $17.83 $160,110 - $481,409	27,000 New	27,000 $129,000
Q2 2021 Aug 11, 2021	SELL	$13.54 - $22.74 $171,958 - $288,798	-12,700 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$12.91 - $23.83 $163,957 - $302,641	12,700 New	12,700 $31,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.